Skip to content

Study of COVID-19 infection

The Prevalence of Pre-Diabetes in SARS-Cov-2 positivity in COVID-19 pandemic. - Study of SARS-Cov-2 positivity

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050905
Enrollment
50
Registered
2023-04-24
Start date
2020-09-11
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance

Interventions

None listed

Sponsors

Toho University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Men and woman between 20 and 100 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Methods of infection control for COVID-19

Countries

Japan

Contacts

Public ContactHiroshi Uchino

Toho University Graduate School of Medicine Division of Diabetes Metabolism and Endocrinology Department of Internal Medicine

h.uchino@med.toho-u.ac.jp03-3762-4151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026